China · Delayed Price · Currency is CNY Intercept Pharmaceuticals Statistics
Total Valuation
SHE:300737 has a market cap or net worth of CNY 5.94 billion. The enterprise value is 7.23 billion.
| Market Cap | 5.94B |
| Enterprise Value | 7.23B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | Jun 4, 2025 |
Share Statistics
SHE:300737 has 1.11 billion shares outstanding. The number of shares has increased by 5.73% in one year.
| Current Share Class | 1.11B |
| Shares Outstanding | 1.11B |
| Shares Change (YoY) | +5.73% |
| Shares Change (QoQ) | +25.86% |
| Owned by Insiders (%) | 42.14% |
| Owned by Institutions (%) | 9.57% |
| Float | 526.41M |
Valuation Ratios
The trailing PE ratio is 195.44 and the forward PE ratio is 21.23.
| PE Ratio | 195.44 |
| Forward PE | 21.23 |
| PS Ratio | 0.88 |
| PB Ratio | 1.18 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | 9.05 |
| P/OCF Ratio | 6.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.62, with an EV/FCF ratio of 11.02.
| EV / Earnings | 227.14 |
| EV / Sales | 1.07 |
| EV / EBITDA | 32.62 |
| EV / EBIT | n/a |
| EV / FCF | 11.02 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.96.
| Current Ratio | 1.57 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 21.77 |
| Debt / FCF | 7.36 |
| Interest Coverage | -0.55 |
Financial Efficiency
Return on equity (ROE) is 0.40% and return on invested capital (ROIC) is -0.33%.
| Return on Equity (ROE) | 0.40% |
| Return on Assets (ROA) | -0.23% |
| Return on Invested Capital (ROIC) | -0.33% |
| Return on Capital Employed (ROCE) | -0.66% |
| Revenue Per Employee | 1.80M |
| Profits Per Employee | 8,496 |
| Employee Count | 3,748 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 9.48 |
Taxes
In the past 12 months, SHE:300737 has paid 24.08 million in taxes.
| Income Tax | 24.08M |
| Effective Tax Rate | 54.21% |
Stock Price Statistics
The stock price has increased by +22.43% in the last 52 weeks. The beta is 1.40, so SHE:300737's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +22.43% |
| 50-Day Moving Average | 5.02 |
| 200-Day Moving Average | 5.10 |
| Relative Strength Index (RSI) | 54.42 |
| Average Volume (20 Days) | 37,927,608 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300737 had revenue of CNY 6.74 billion and earned 31.84 million in profits. Earnings per share was 0.03.
| Revenue | 6.74B |
| Gross Profit | 1.45B |
| Operating Income | -50.90M |
| Pretax Income | 44.42M |
| Net Income | 31.84M |
| EBITDA | 209.63M |
| EBIT | -50.90M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 3.62 billion in cash and 4.83 billion in debt, giving a net cash position of -1.20 billion or -1.09 per share.
| Cash & Cash Equivalents | 3.62B |
| Total Debt | 4.83B |
| Net Cash | -1.20B |
| Net Cash Per Share | -1.09 |
| Equity (Book Value) | 5.03B |
| Book Value Per Share | 4.45 |
| Working Capital | 3.66B |
Cash Flow
In the last 12 months, operating cash flow was 910.38 million and capital expenditures -254.25 million, giving a free cash flow of 656.13 million.
| Operating Cash Flow | 910.38M |
| Capital Expenditures | -254.25M |
| Free Cash Flow | 656.13M |
| FCF Per Share | 0.59 |
Margins
Gross margin is 21.55%, with operating and profit margins of -0.76% and 0.47%.
| Gross Margin | 21.55% |
| Operating Margin | -0.76% |
| Pretax Margin | 0.66% |
| Profit Margin | 0.47% |
| EBITDA Margin | 3.11% |
| EBIT Margin | -0.76% |
| FCF Margin | 9.74% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 7.10%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 7.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 406.10% |
| Buyback Yield | -5.73% |
| Shareholder Yield | 1.37% |
| Earnings Yield | 0.54% |
| FCF Yield | 11.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 1, 2021. It was a forward split with a ratio of 1.8.
| Last Split Date | Jul 1, 2021 |
| Split Type | Forward |
| Split Ratio | 1.8 |
Scores
SHE:300737 has an Altman Z-Score of 1.35 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.35 |
| Piotroski F-Score | 5 |